Keratomileusis, Laser In Situ

NEW YORK — The integration of SMILE into clinical practice takes patience and the willingness to experience a learning curve, a speaker said here.

SAN FRANCISCO — Using VisuMax Circle enhancement after SMILE results in less pain and a shorter recovery time than surface ablation, according to a speaker here.

SAN FRANCISCO — Patients who have received a multifocal lens may be in need of further refractive error correction, and with many multifocal lenses entering the market, this is something refractive surgeons should be aware of and prepared for, as well as discuss with patients, according to a speaker here.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Schwind eye-tech-solutions launched the ATOS femtosecond laser, with capabilities for both femtoLASIK and innovative lenticule extraction with the SmartSight technology.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Noel Alpins, MD, gives pearls on how to prevent residual corneal astigmatism and related nighttime visual phenomena in LASIK patients. He also gives instructions on how to get access to an online free vector planning calculator.

They say technology reaches its pinnacle when it becomes invisible. In other words, the best technologies work for us without requiring any conscious attention. Current presbyopia-correcting lens implants require us to make a choice between some degree of monovision and the limited optics of diffractive or extended depth of focus designs. Both of these compromises can lead to frustration for at least some patients some of the time. An adjustable lens such as the RxSight Light Adjustable Lens can offer a much higher degree of surgical accuracy. In clinical trials, 92% of patients were within 0.5 D of their refractive target, and 70% saw 20/20 unaided. The Perfect Lens (Perfect Lens), which uses a femtosecond laser to adjust the refractive index of an acrylic lens inside the eye, has the potential to refine refractive outcomes within 0.1 D of target refraction, although no clinical trial results are yet available. This kind of refractive accuracy is worth a lot. But so far, these lenses do not correct presbyopia and therefore require significant patient counseling and careful selection to find the right fit for monovision.

Bausch + Lomb has initiated the first clinical trial for its Technolas Teneo excimer laser for myopia and myopic astigmatism correction surgery, the company announced in a press release.